RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 142 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,180,000 | -10.5% | 344,900 | -8.5% | 0.00% | 0.0% |
| Q4 2020 | $1,319,000 | +43.1% | 376,758 | -1.9% | 0.00% | 0.0% |
| Q3 2020 | $922,000 | +34.2% | 384,058 | +2.2% | 0.00% | 0.0% |
| Q2 2020 | $687,000 | +17.4% | 375,658 | +0.2% | 0.00% | 0.0% |
| Q1 2020 | $585,000 | -43.0% | 374,858 | -21.8% | 0.00% | 0.0% |
| Q4 2019 | $1,026,000 | +4.6% | 479,658 | -8.5% | 0.00% | 0.0% |
| Q3 2019 | $981,000 | -19.3% | 524,458 | +12.6% | 0.00% | 0.0% |
| Q2 2019 | $1,215,000 | -1.5% | 465,600 | -3.0% | 0.00% | -50.0% |
| Q1 2019 | $1,234,000 | +11.8% | 480,000 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $1,104,000 | -32.3% | 480,000 | -5.5% | 0.00% | 0.0% |
| Q3 2018 | $1,631,000 | +4.7% | 508,094 | -7.7% | 0.00% | 0.0% |
| Q2 2018 | $1,558,000 | -50.1% | 550,694 | -37.5% | 0.00% | -50.0% |
| Q1 2018 | $3,121,000 | -8.7% | 881,500 | 0.0% | 0.00% | -20.0% |
| Q4 2017 | $3,420,000 | +52.7% | 881,500 | 0.0% | 0.01% | +66.7% |
| Q3 2017 | $2,239,000 | -6.9% | 881,500 | 0.0% | 0.00% | -25.0% |
| Q2 2017 | $2,406,000 | -17.5% | 881,500 | 0.0% | 0.00% | -20.0% |
| Q1 2017 | $2,918,000 | +39.1% | 881,500 | 0.0% | 0.01% | +25.0% |
| Q4 2016 | $2,098,000 | -35.1% | 881,500 | 0.0% | 0.00% | -20.0% |
| Q3 2016 | $3,235,000 | +64.5% | 881,500 | 0.0% | 0.01% | +66.7% |
| Q2 2016 | $1,966,000 | +7.2% | 881,500 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $1,834,000 | -31.3% | 881,500 | 0.0% | 0.00% | -25.0% |
| Q4 2015 | $2,671,000 | +22.7% | 881,500 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $2,177,000 | -23.1% | 881,500 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $2,830,000 | +108.4% | 881,500 | +39.5% | 0.00% | +100.0% |
| Q1 2015 | $1,358,000 | 0.0% | 631,700 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $1,358,000 | +1123.4% | 631,700 | +1004.4% | 0.00% | – |
| Q3 2014 | $111,000 | -46.6% | 57,200 | 0.0% | 0.00% | – |
| Q2 2014 | $208,000 | +9.5% | 57,200 | 0.0% | 0.00% | – |
| Q1 2014 | $190,000 | +25.8% | 57,200 | 0.0% | 0.00% | – |
| Q4 2013 | $151,000 | -30.4% | 57,200 | -5.8% | 0.00% | – |
| Q3 2013 | $217,000 | +123.7% | 60,702 | +108.6% | 0.00% | – |
| Q2 2013 | $97,000 | – | 29,102 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 8,350,000 | $28,557,000 | 5.86% |
| Ion Asset Management Ltd. | 3,632,132 | $12,422,000 | 1.43% |
| CM Management, LLC | 500,000 | $1,710,000 | 1.27% |
| SECTOR GAMMA AS | 1,530,490 | $5,234,000 | 0.96% |
| Rhenman & Partners Asset Management AB | 1,520,000 | $5,198,000 | 0.36% |
| Rock Springs Capital Management LP | 4,742,000 | $16,218,000 | 0.35% |
| Telemetry Investments, L.L.C. | 90,000 | $308,000 | 0.35% |
| DAFNA Capital Management LLC | 275,500 | $942,000 | 0.22% |
| KELLEHER FINANCIAL ADVISORS | 100,000 | $342,000 | 0.22% |
| Virtus ETF Advisers LLC | 91,971 | $315,000 | 0.13% |